Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats

Journal of Molecular and Cellular Cardiology

Volumn 33, Issue 3, 2001, Pages 395-403

  Bachetti, Tiziana ^a   Comini, Laura ^a   Pasini, Evasio ^a   Cargnoni, Anna ^a   Curello, Salvatore ^b   Ferrari, Roberto ^c  

^a IRCCS   (Italy)

^b SPEDALI CIVILI   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Angiotensin converting enzyme inhibitors; Bradykinin; Endothelial and inducible nitric oxide synthases; Endotoxin

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CITRULLINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTOXIN; ICATIBANT; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; QUINAPRIL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR ENDOTHELIUM;

EID: 0034970747     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1311     Document Type: Article

References (39)

1. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide
2. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
3. Nitric oxide synthases in the cardiovascular system
4. Endothelial dysfunction in human disease
5. Endothelial dysfunction: From physiology to therapy
6. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease
7. Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans
8. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure
9. Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: Evidence for a causal link
10. Alterations of nitric oxide synthase expression with aging and hypertension in rats
11. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats?
12. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension
13. Hoe-140, a new potent and long-acting bradykinin antagonist: In vivo study
14. Detection of nitric oxide in exhaled air of different animal species using a clinical chemiluminescence analyser
15. Aorta and skeletal muscle NO-synthase expression in experimental heart failure
16. Protein measurement with the folin phenol reagent
17. Cleavage of structural proteins during assembling of the head of bacteriophage T4
18. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure
19. The role of nitric oxide in cardiac depression induced by interleukin-1β and turmour necrosis factor-α
20. Nitrite and nitrate determinations in plasma: A critical evaluation
21. Long-term ACE inhibition doubles lifespan of hypertensive rats
22. Angiotensin-converting enzyme inhibition alters nitric oxide and superoxide release in normotensive and hypertensive rats
23. 2 kinin receptors in cultured porcine endothelial cells
24. 2 receptors in adult myocardium and neonatal rat cardiomyocytes
25. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene
26. Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failure
27. Serum from patients with severe heart failure down-regulates ecNOS and is pro-apoptotic: Role of the TNF-α
28. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life
29. Nitric oxide synthases: Gene structure and regulation
30. Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-alpha in vitro and in vivo
31. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production
32. Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit
33. The dual personality of NO
34. Tumor necrosis factor in congestive heart failure: A mechanism of disease for the new millennium?
35. Endotoxin and immune activation in chronic heart failure: A prospective cohort study
36. Endothelial function and atherosclerosis
37. Endothelial function in health and disease: New insights into the genesis of cardiovascular disease
38. Endothelial dysfunction in hypertension
39. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients